How much will Moderna increase its 2021 vaccine production?

Question

Accepted Answer

Moderna Increases 2021 Global Covid-19 Vaccine Production Target to 700 Million Doses

Moderna announced an increase in its global Covid-19 vaccine production goal for 2021, raising the target by 100 million doses to a total of 700 million. This adjustment reflects ongoing efforts to scale up manufacturing capacity and potentially combat emerging variants of the virus.
Increased Production Goal for 2021

The US biotech firm has revised its projected global vaccine output for the current year. The new target of 700 million doses represents a significant increase from the previously stated goal of 600 million doses. This upward revision is supported by ongoing improvements to Moderna's manufacturing processes.
Development of Variant-Targeting Booster Shots

In parallel with production scaling, Moderna is actively engaged with US government scientists to develop and study an experimental booster shot. This new formulation is specifically designed to target concerning variants of the coronavirus, including the one first identified in South Africa, which may exhibit increased resistance to existing vaccines.
Exploration of Additional Manufacturing Capacity

Beyond the immediate 2021 target, Moderna is also investing in expanding its manufacturing capabilities. The company is exploring further enhancements to its production processes that could potentially allow for an output of up to 1 billion doses within 2021. Furthermore, planned investments in additional manufacturing capacity are expected to support a global production of approximately 1.4 billion doses in 2022, an increase from the prior projection of 1.2 billion doses.

Reading history

Hide →

This history is cleared when the page is closed.

How much will Moderna increase its 2021 vaccine production?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends